At a glance
DRSK charges 0.79% a year, below the 0.86% average of the 7 funds most like it (the cheapest of 8). It has $1.51B in assets, the 3rd largest of that group; it paid 4.0% of its price in distributions over the past 12 months, quarterly. Over the past year it returned −4.1% with distributions reinvested (S&P 500: +11.5%), the weakest of those 8 funds; over three years it returned +10.0% a year. At its worst it fell 8.2% in the 2020 crash (S&P 500: 33.7%) and 11.7% in the 2022 bear market (S&P 500: 24.5%), and was back at its earlier high within a month and 20 months after the lows.
The short version
The Aptus Defined Risk ETF (DRSK) is an actively managed fund of funds. It puts 75% to 95% of its assets into investment-grade bond ETFs and gets its stock exposure by purchasing options rather than shares, with put options meant to limit losses. Unlike buffer funds, it has no preset floor. Its 0.79% expense ratio is below the 0.86% average of the buffer funds it is often grouped with.
Price history
The interactive chart needs JavaScript.
DRSK -4.1% over the year to Oct 27, 2026, total return with distributions reinvested.
How it has behaved
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | Since start | |
|---|---|---|---|---|---|---|
| DRSK official prospectus, to Dec 31, 2025 | — | +7.82% | — | +2.43% | — | +5.46% |
| DRSK price data to Oct 27, 2026 | -1.5% | -4.1% | +10.0% | +2.1% | — | +4.7% |
- Over the year to Oct 27, 2026, DRSK returned -4.1%, 8th of 8 among similar funds.
- Its 5-year annualized return was +2.1%.
- In the 2020 COVID crash it fell 8.2% and regained its old high 0.9 months after the low.
- Its worst full calendar year was 2022 (-9.6%); its best was 2020 (+13.8%).
- The deepest fall in its price history was 19.9% (Nov 5, 2021 to Oct 31, 2023), recovered by Aug 15, 2024.
Show as a table
| Year | Price data | Prospectus (official) |
|---|---|---|
| 2026 (to date) | -1.5% | — |
| 2025 | +7.7% | +7.82% |
| 2024 | +12.4% | +12.37% |
| 2023 | +2.1% | +2.00% |
| 2022 | -9.6% | -9.43% |
| 2021 | +0.8% | +0.75% |
| 2020 | +13.8% | +13.98% |
| 2019 | +12.6% | +12.90% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Before this security existed |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Lost 4.4% over that stretch · deepest drop along the way 8.2%, back to its old high 0.9 months after the low |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Lost 11.7% over that stretch · deepest drop along the way 11.7%, back to its old high 20.1 months after the low |
Dividends and income
Show as a table
| Year | Per share | Change |
|---|---|---|
| 2026 (to date) | $0.7900 | |
| 2025 | $1.0400 | +16.9% |
| 2024 | $0.8900 | -1.1% |
| 2023 | $0.9000 | +83.7% |
| 2022 | $0.4900 | -34.7% |
| 2021 | $0.7500 | -54.8% |
| 2020 | $1.6600 | +102.4% |
| 2019 | $0.8200 |
What's inside
As of Jul 31, 2026, the fund held 10 securities; the ten largest made up 94.3% of assets.
| Fund held | Weight | |
|---|---|---|
| Invesco BulletShares 2032 Corporate Bond ETF | 12.07% | |
| Invesco Bulletshares 2031 Corporate Bond ETF | 11.78% | |
| Invesco BulletShares 2033 Corporate Bond ETF | 11.07% | |
| iShares iBonds Dec 2032 Term Corporate ETF | 10.78% | |
| iShares iBonds Dec 2031 Term Corporate ETF | 10.42% | |
| Invesco BulletShares 2030 Corporate Bond ETF | 10.37% | |
| iShares iBonds Dec 2029 Term Corporate ETF | 10.06% | |
| iShares iBonds Dec 2030 Term Corporate ETF | 8.93% | |
| Invesco BulletShares 2034 Corporate Bond ETF | 4.79% | |
| iShares iBonds Dec 2034 Term Corporate ETF | 4.04% |
By country
United States 94.3%By asset type
Stocks 94.3%What changed recently
- Over the three months to Jul 31, 2026, investors added a net $42.3M (creations minus redemptions, per the N-PORT report).
- Monthly total returns reported for that quarter: +3.49%, -1.85%, -1.16%.
How it works
DRSK doesn't track an index. Aptus Capital Advisors, the fund's adviser, splits the portfolio between bonds and stocks. Typically 75% to 95% goes into bond ETFs that track indexes of investment-grade bonds, which are bonds rated as having a lower risk of default. As of July 31, 2026, ten term corporate bond ETFs from Invesco BulletShares and iShares iBonds made up 94.3% of assets. Each holds bonds that mature around a single year, from 2029 to 2034. The largest were BSCW at 12.1% and BSCV at 11.8%. The bond side is rebalanced quarterly.
The stock side uses call options. A call option is the right to purchase a stock at a set price before a set date, in exchange for an upfront payment called a premium. Aptus chooses stocks with a "yield plus growth" screen that looks at yield, growth, valuation and momentum. It may also use options on indexes or ETFs. The options run one week to six months and are reset monthly, with 0.25% to 1.00% of assets per stock. The fund may also write calls, which brings in premium but limits gains above the strike price. It also uses put options to limit losses when markets fall. As of July 31, 2026, options made up 1.31% of assets, led by calls on Amazon and Broadcom. If stocks fall, a call can lose its whole premium, but no more.
What it really costs
- DRSK charges 0.79% a year, versus an average of 0.86% for the similar funds below (1st of 8, cheapest first).
- Of that, 0.69% is the management fee; the rest covers other fund expenses.
- Using the prospectus's standard example, $10,000 invested would cost about $81 in the first year and $978 over 10 years (assuming a 5% annual return).
| Cost of $10,000 (SEC example) | 1 yr | 3 yrs | 5 yrs | 10 yrs |
|---|---|---|---|---|
| DRSK | $81 | $252 | $439 | $978 |
Structure and tax notes
- Invests in other funds rather than directly in stocks or bonds, so its holdings are those funds.
In a retirement portfolio
Most of the fund is in investment-grade corporate bond ETFs, with only a small, options-based slice tied to stocks.
DRSK could add a mostly-bond holding with some stock upside. Its trailing 12-month yield was 4% ($1.09 per share) as of October 27, 2026, paid quarterly. It launched in 2018, so it has no record from 2008. In the 2020 COVID crash it fell 8.2% and recovered within a month. In the 2022 bear market it fell 11.7% and did not recover until June 2024. Its worst calendar year was 2022, at -9.43%. Its deepest drop, 19.9% from November 2021 to October 2023, was not made up until August 2024. That is a reminder that its bonds carry interest-rate risk, and that money withdrawn during those years came out of a smaller balance. In the SEC's standard example, costs on $10,000 come to $81 after one year and $978 after ten. Past results don't predict future returns, and a plan should look at the whole portfolio, not one fund.
Who it may suit — and who should look elsewhere
May suit
- Investors wanting mostly investment-grade corporate bond ETFs plus a small, options-based slice of US stock upside, all in one actively managed fund.
- Income seekers comfortable with quarterly payouts; the trailing 12-month yield was 4% as of October 27, 2026.
- Those who value smaller swings: one-year volatility was 7.6%, and beta (how much it moves with the stock market) was 0.42, as of October 27, 2026.
Look elsewhere if
- Investors wanting a defined buffer or floor; DRSK's puts aim to limit losses but promise nothing, and it once fell 19.9% from peak to trough.
- Cost-focused investors: 0.79% a year is a lot to pay for a fund whose largest holdings are term corporate bond ETFs.
- Investors wanting strong stock-market gains: its one-year return was -4.1%, versus 9.5% to 12.9% for equity buffer funds, as of October 27, 2026.
Close alternatives
Matched by other buffer (defined-outcome) funds, largest first.
| Fund | Cost | Net assets | 1 yr | 3 yr |
|---|---|---|---|---|
| DRSK this fund | 0.79% | $1.51B | -4.1% | +10.0% |
| BUFR FT Vest Laddered Buffer ETF | 0.95% | $10.49B | +11.6% | +16.8% |
| BUFD FT Vest Laddered Deep Buffer ETF | 0.95% | $2.04B | +9.5% | +13.9% |
| PJAN Innovator U.S. Equity Power Buffer ETF - Ja… | 0.79% | $1.44B | +10.5% | +14.8% |
| PDEC Innovator U.S. Equity Power Buffer ETF - De… | 0.79% | $984.1M | +11.6% | +14.9% |
| FDEC FT Vest US Equity Buffer ETF - December | 0.85% | $1.31B | +12.9% | +18.5% |
| FJAN FT Vest US Equity Buffer ETF - January | 0.85% | $1.47B | +12.3% | +17.4% |
| FFEB FT Vest U.S. Equity Buffer Fund - February | 0.85% | $1.42B | +12.9% | +18.6% |
Questions investors ask
Is DRSK a buffer ETF?
No. DRSK is often grouped with buffer funds, but it doesn't offer a preset buffer or cap over a set period. It keeps 75% to 95% of its assets in investment-grade bond ETFs. It gets stock exposure through call options and uses put options to try to limit losses. That design is meant to reduce risk, but it guarantees nothing. The fund's deepest drop was 19.9%, from November 2021 to October 2023.
Does DRSK pay monthly dividends?
No. DRSK pays quarterly, even though the bond ETFs it holds generally pay monthly. As of October 27, 2026, its trailing 12-month yield was 4%, or $1.09 per share. Most of that income comes from the corporate bonds inside its underlying ETFs, so payouts can change with interest rates and with what the adviser holds.
What does DRSK actually hold?
Mostly other ETFs. As of July 31, 2026, ten term corporate bond ETFs made up 94.3% of assets. The largest were Invesco BulletShares 2032 (BSCW) at 12.1%, BulletShares 2031 (BSCV) at 11.8% and BulletShares 2033 (BSCX) at 11.1%. Another 1.31% was in 23 option positions, led by calls on Amazon, Broadcom and Vistra plus an S&P 500 put. Cash was 1.2%.
How did DRSK do in 2022?
It lost 9.43% in 2022, its worst calendar year, according to its prospectus. The worst quarter was the second, at -5.57%. Over the 2022 bear market it fell 11.7% from January 3 to October 11 and didn't recover until June 2024. Bonds, which make up most of the fund, also lose value when interest rates rise, so its large bond allocation offered limited protection that year.
What's the difference between DRSK and BUFR?
They follow different strategies. BUFR, the FT Vest Laddered Buffer ETF, is a stock-based buffer fund. DRSK is mostly bonds plus stock options. BUFR costs 0.95% a year and DRSK 0.79%. As of October 27, 2026, BUFR returned 11.6% over one year and 16.8% a year over three years. DRSK returned -4.1% and 10% over the same periods. BUFR held $10.5 billion as of August 31, 2026, versus DRSK's $1.5 billion as of July 31, 2026.